As certain psychedelic drugs receive "breakthrough" status from the FDA for the treatment of serious mental-health conditions, the wellness industry is looking to commodify the science—with a polarizing response from the medical community. Maya Singer, turns on, tunes in, and drops some knowledge.

Find the full story here. For more from Maya Singer and VOGUE, make sure to subscribe to VOGUE Stories on:

or wherever you listen to podcasts.

Learn more about your ad choices. Visit podcastchoices.com/adchoices